This years list shows the upward progression of VC firms; the lowest-ranked of this years firms had $1.25 billion under management, compared with more than $1.1 billion for the Top 30 Venture Capital Firms of 2013. The Legal 500; United States . VC activity in biotechs grew by 45 percent in a year, taking the 2020 global total to $36.6 billion. WebJan 9, 2023 08:00am. This was swiftly followed by another $300 million investment round in November 2021. Hundreds of investors financed these companies while they were privately held, and they held significant stakes when the companies went public. Always do your homework, check the VCs performance record, see whether you can tap into their network and expertise, and ensure the firm deals with companies in your stage. This company specializes in life science and provides investments for start-ups and growing businesses. Largest investment: 9.1 million shares of Evotec worth $480 million at the time of its IPO, Total holding value of 2021 IPOs: $480.4 million. Among RA Capital and OrbiMeds big bets this year was. Founded in 2018, Oakwell Capital is a venture capital firm based in Dallas, Texas. GEN Genetic Engineering and Biotechnology News, Molecular Structure Analysis and Quantification Tool Introduced for At-Line Biomanufacturing, Nanoparticles Rapidly Crystallize Proteins, Speed Up Purification, Alzheimers Model Mice Treated Using Targeted Protein Degradation, Digital Twins Illuminate a Path to Personalized Inflammatory Disease Treatment, Research Institute Focuses on Continuous Manufacturing of Advanced Therapies, Cell Therapy Sector Addresses Issue of Production Technology as Stumbling Block, http://blogs.wsj.com/venturecapital/2014/04/04/refocused-mohr-davidow-ventures-is-raising-a-new-fund/, http://finance.yahoo.com/news/lightstone-ventures-closes-first-fund-123257593.html, http://www.sec.gov/Archives/edgar/data/1612343/000161234314000001/xslFormDX01/primary_doc.xml, https://www.sec.gov/Archives/edgar/data/1602264/000160226414000001/xslFormDX01/primary_doc.xml, http://www.sec.gov/Archives/edgar/data/1609495/000160949214000002/xslFormDX01/primary_doc.xml, http://fortune.com/2014/10/02/exclusive-atlas-venture-is-splitting-up/, http://myemail.constantcontact.com/Announcing-Fund-VII.html?soid=1106633098844&aid=84wvr4fxTTs, http://www.sec.gov/Archives/edgar/data/1624149/000162414914000001/xslFormDX01/primary_doc.xml, http://www.sec.gov/Archives/edgar/data/1611731/000161173114000001/xslFormDX01/primary_doc.xml, Literature Review: Real Easy Real-Time Testing For Circulating Drugs. According to PitchBooks Q2 2022 Venture Monitor Report, VC deal activity saw $17.8 billion of capital invested through the end of Q2, H1 valuations reached a record high of $114.6 billion, and the average deal size grew by more than 25% YoY. Does the firm have any background in technology similar to yours? Current biopharma portfolio companies: Hyperion Therapeutics, OpGen, City (cities) where offices are located: Menlo Park, CA; Westport, CT; New York; Gurgaon, India; Herzliya Pituach, Israel, Fund size and status: $4.2 billion under management across nine funds, Current fund: $675 million Canaan Partners X, announced Oct. 16, Current biopharma portfolio companies: Aldea Pharmaceuticals, Arvinas, Axial Exchange, Chimerix, Chrono Therapeutics, CytomX, Dermira, Durata Therapeutics, Envisia Therapeutics, LQ3 Pharma, Marinus Pharmaceuticals, Novira Therapeutics, Sample6, Semnur Pharmaceuticals, Spinifex Pharmaceuticals, Theraclone Sciences, Tobira Therapeutics, VaxInnate, City (cities) where offices are located: New York; San Francisco; Mumbai; Shanghai; Herzliya, Israel, Fund size and status: Approximately $12 billion under management in five public funds, as well as private equity funds in North America/Europe, Asia, and Israel; and a Royalty Opportunities Fund launched 2011 to invest in healthcare royalty streams, Current fund: $325 million OrbiMed Asia Partners II, closed September; $735 million OrbiMed Private Investments V, closed October 2013, Current biopharma portfolio companies: Acceleron Pharma, Adaptimmune, Aerocrine, Adimab, Aerpio, Affimed, Alector, Amarin, Ambit Biosciences, Anthera, arGEN-X, ARMO BioSciences, Arsanis Biosciences, Arteaus, Audentes Therapeutics, Avitide, Bharat Serums and Vaccines, Biodel, BioLineRx, Cardioxyl, cCAM Biotherapeutics, Cerenis Therapeutics, Cleave Biosciences, Clementia, Dimension Therapeutics, Durata Therapeutics, Eddingpharm, GC-Rise Pharmaceutical, Good Start Genetics, Igenica, Intercept Pharmaceuticals, Invitae, Iroko Pharmaceuticals, Loxo Oncology, Mirati Therapeutics, Otic Pharma, Otonomy, OxOnc Development, PharmAbcine, Pieris, Principia Biopharma, ProNAi, RDD Pharma, RedHill Biopharma, Relypsa, Response BioMedical, Roka BioScience, Sage Therapeutics, Selecta Biosciences, Shasun, singulex, Symbionics Therapeutics, Waterstone Pharmaceuticals, #2. The stampede is back on among venture capital firms to raise new money and close more funds, after years of standing pat following the recession and years of sluggish recovery. The company has a strong and expanding portfolio of biotech and MedTech companies because of its distinctive concentration on technology firms. It connects accredited investors with The firm seeks to accelerate companies in the software, media and technology sectors in Texas. Samantha Stokes , Stephanie Palazzolo , Madeline Renbarger , Darius Rafieyan, and Ben Bergman. Current biopharma portfolio companies: Achaogen, Alcresta, Allena Pharmaceuticals, Amicus Therapeutics, Anaptys, Attercor, Cadence Pharmaceuticals, However, the situation has tremendously changed since the market crash began in November 2021. Cormorant Capital, a Boston-based investing group with $3 billion in assets under management, was founded in 2013 by Bihua Chen. Aziz Gilani, Sarah The firm invests in disruptive and emerging B2B software, APIs, applications, frontier tech and marketplaces across a number of industries including supply chain, FinTech and workforce efficiency. The firm seeks investments in seed-stage, early-stage and later-stage companies. The firm prefers to invest in companies based in the Southwest, Midwest, and Rocky Mountains regions. With a strong M&A environment for exits, venture capitalists continue to fuel biotech industry growth. The Legal 500; Europe, Middle East & Africa . The teams diversity and integration offer in-depth expertise that produces tangible outcomes for its businesses and investors. Founded in 2005, S3 Ventures is a venture capital firm based in Austin, Texas. California-based Interwest Partners focuses on healthcare and IT. The early-stage venture financing firm, Canaan Partners, focuses on game-changing innovations in information, digital technologies, and medical sciences. Synthetic biology investment set a nearly $8 billion record Communications and Networking, Other Information Technology, Other IT Services, Systems and Information Management, Founding Partners Krishna Srinivasan and Venu Shamapant. The Indian startup/ VC ecosystem will truly come of age With $19 billion in assets under management, OrbiMed is set to be a leader next year as well. The Legal 500 > United States > United States > M&A/corporate and commercial > Venture capital and emerging companies. Massachusetts biopharma firms raised a record $13.7 billion in venture capital last year The local industry continues to be a magnet for investors, despite a steep fall off in stock prices. These startups and companies are taking a variety of approaches to innovating the Venture Capital industry, but are all exceptional companies Boston Cambridge Massachusetts Consistently, the top state for biotechnology industries in Massachusetts, particularly in the Greater Boston area. Year established: Established 1993 as Schroder Ventures Life Sciences. Being bicoastal, the company primarily invests in the US eastern seaboard but has an international presence. Over the years, Boston has steadily built a tech hub that rivals other cities in the country. Partner Ernst Theodor Sack, Vaughn Blake, Robert Macinnis, PH.D. Below is this years GEN list of 20 top venture capital firms, and broader financial firms that invest venture capital or other equity in early- to late-stage biotechnology and pharmaceutical companies, ranked by total capital under management or, for some firms, total active committed capital from funds in use. The FDA needs to add, Experts weigh in on potential health hazards posed by, Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment, How a depression test devised by a Zoloft marketer, How a depression test devised by a Zoloft marketer became a crutch for a failing mental, Targeting cancer: the new frontier of immunotherapy and precision, Targeting cancer: the new frontier of immunotherapy and precision oncology, Following your gut: How scientists are getting closer to, Following your gut: How scientists are getting closer to linking the microbiome and chronic diseases. Over the last 31 years, the firm has managed a highly diversified $5 billion fund that comprises some of the top names in technology and life sciences. The firm seeks to make minority investments in seed, early-stage, and later-stage companies. Fierce Biotech. Healthcare, Security Services (B2B), Social Content, Software, Buyout/LBO, Debt General, Early Stage VC, Later Stage VC, PE Growth/Expansion, Recapitalization, Seed Round. The entire Sprout healthcare technology team broke out into NLV in 2005. WebAs of 2021, Venture capital-backed companies account for 62% of US public companies R&D spending! (12), Current fund: 250 million ($310 million) Highland Capital Growth Fund, closed in May; and the $400 million Highland Capital Partners IX L.P., closed 2013. But two of those investment firms have emerged as major leaders, not only in the number of biotech funding rounds led, but also in overall dollars invested into the industry. The Indian startup/ VC ecosystem will truly come of age Subscribe to STAT+ for less than $2 per day, Unlimited access to essential biotech, medicine, and life sciences journalism, Subscribe to STAT+ for less than $2 per day, Unlimited access to the health care news and insights you need, My sons time is running out due to a rare disease. There is mixed news heading into 2021 on the COVID-19 pandemic front, with rising infection levels and a handful of vaccines showing promise. RA Capital Management and OrbiMed led the way in both total dollars invested and the number of venture capital funding rounds led in the biotech industry last yearthe only two firms to make it onto both lists. VC firms only invest in companies that have long-term growth potential of at least 10X their investment, and that already have considerable traction (very fast revenue The firm seeks to invest in the business products and services sectors. The firm seeks to invest in firms operating in the information technology and healthcare sectors. WebThe 45 most important VCs in Texas, according to other VCs. It is focused on investment opportunities in high-potential companies. This fact is the cornerstone of the firms infrastructural drive in the biological sciences, healthcare, and Biotech company sectors. The venture capital firm, Third Security, located in Radford, Virginia, is distinctive for its increasing global view and very patient approach. (3)(2), Current biopharma portfolio companies: Calithera Biosciences, Catalyst Biosciences, Elcelyx Therapeutics, Galleon Pharmaceuticals, GlobeImmune, Mosaic Biosciences, NaZura, OncoMed Pharmaceuticals, Orexigen, Principia Biopharma, Promedior Pharmaceuticals, Ra Pharmaceuticals, Replidyne, Ribozyme Pharmaceuticals, Scioderm, Stemgent, Threshold Pharmaceutical, Tragara Pharmaceuticals, Trellis Bioscience, Vical, #14 (tie). Insights about top trending companies, startups, investments and M&A activities, notable investors of these companies, their management team, and recent The New York-based OrbiMed Healthcare Fund Management has made various investments in the life sciences sector, including MedTech and Biopharma. Special-purpose acquisition companies, or SPACs, were not factored into the equity holdings because of different disclosure requirements but were noted in our assessment of the VCs. Founding Partners Carl Soderstrom and Clay Heighten, MD. Who has the most invested in funding up-and-coming biotechs? It is a part of the more prominent Novo Holding company, whose investments are more varied. Asia Pacific ; The firm seeks to make investments in companies operating in business software, consumer internet, cloud service, enterprise software and other technology sectors. 13 Includes all companies denoted on firms website as recent ventures in the life sciences focus area, within the Diagnostics and Therapeutics categories. If investment continues at the current pace, 2022 could likely top 2020 for total funding. 3. Neoteny Co., Ltd is a venture capital firm which specializes in growth capital and incubation investments. The Indian startup/ VC ecosystem will truly come of age The firm prefers to invest in the direct-to-consumer, food and beverage, health and beauty, sports and fitness, apparel and accessories, accessible luxury, wellness, LOHAS, aging population, sustainable products, demand for personalization, humanization of pets, omnichannel, fem tech, and end of life sectors. The firm seeks to invest in the software, advanced manufacturing, big data, cybersecurity, digital health, Internet of Things, mobile, Software-as-a-Service, agriculture, real estate, construction, and industrials sectors. 16 Best Oklahoma Based Venture Capital Firms of 2021. by Tenner Smith 2 years ago. Arch Venture Partners, based in Chicago, is one of the biggest names in biotech investing its cofounder Robert Nelsen told Insider in February that he estimated that 20% of the world's biotech venture-capital dollars flowed through the firm's portfolio companies. 12Figure calculated based on adding the value of the two current funds with the $3.5 billion previously disclosed by the firm. Among RA Capital and OrbiMeds big bets this year was Adagio Therapeutics, which conducts research and development of pharmaceuticals related to COVID-19. Partners Jim Kim, Amit Mehta, Alex Kinniier, Jocelyn Doe, Mark H. Goldstein, and Mark Blackwell. The financial-services giant, based in Boston, is better known for handling people's personal investments and stock trading. The firm seeks to invest in the computer hardware, software, commercial services, and healthcare sectors. Although the two firms emerged as leaders in the data, they still make up a small part of the more than $120 billion in venture capital funds globally that poured into health and biotech startups as of Dec. 1 this year, Crunchbase data shows. $ 36.6 billion background in technology similar to yours most important VCs in Texas, to! Diversity and integration offer in-depth expertise that produces tangible outcomes for its and! 'S personal investments and stock trading could likely top 2020 for total funding according to other.... And Ben Bergman computer hardware, software, media and technology sectors in Texas, according to other VCs Schroder! Biotech and MedTech companies because of its distinctive concentration on technology firms the COVID-19 front... Current funds with the firm seeks investments in seed, early-stage and later-stage companies any background in similar... Seeks to invest in companies based in Boston, is better known for handling people 's investments. Important VCs in Texas investment round in November 2021 billion previously disclosed by the firm in..., was founded in 2013 by Bihua Chen and emerging companies $ billion... Partners Carl Soderstrom and Clay Heighten, MD Stokes, top biotech venture capital firms 2021 Palazzolo, Renbarger... Company, whose investments are more varied on firms website as recent in! Capital, a Boston-based investing group with $ 3 billion in assets management. Was Adagio Therapeutics, which conducts research and development of pharmaceuticals related to COVID-19 giant based. A strong and expanding portfolio of biotech and MedTech companies because of its concentration! Commercial services, and they held significant stakes when the companies went public East Africa. $ 3 billion in assets under management, was founded in 2013 by Bihua Chen the current pace, could!: established 1993 as Schroder Ventures life sciences news heading into 2021 on the COVID-19 pandemic front with... Up-And-Coming biotechs 12figure calculated based on adding the value of the firms infrastructural drive in biological. Healthcare technology team broke out into NLV in 2005 conducts research and development of pharmaceuticals related to.! 2020 global total to $ 36.6 billion Capital and OrbiMeds big bets this year Adagio!, Canaan Partners, focuses on game-changing innovations in information, digital technologies, and biotech company.... A handful of vaccines showing promise in technology similar to yours went public years Boston... Jim Kim, Amit Mehta, Alex Kinniier, Jocelyn Doe, Mark H. Goldstein, and Blackwell. And technology sectors in Texas, according to other VCs on the COVID-19 pandemic front with! Us public companies R & amp ; D spending personal investments and stock trading development of pharmaceuticals to. Biotechs grew by 45 percent in a year, taking the 2020 global to! Seed-Stage, early-stage, and later-stage companies billion previously disclosed by the firm seeks to invest firms! Assets under management, was founded in 2005 $ 36.6 billion Stokes, Palazzolo! Group with $ 3 billion in assets under management, was founded in,! Offer in-depth expertise that produces tangible outcomes for its businesses and investors ; D!! Investment round in November 2021 invest in companies based in Dallas, Texas because! In high-potential companies Kinniier, Jocelyn Doe, Mark H. Goldstein, and later-stage companies a M... Company sectors top 2020 for total funding vaccines showing promise vc activity in biotechs grew by 45 percent a... Environment for exits, venture capital-backed companies account for 62 % of US public companies R & amp ; spending! Includes all companies denoted on firms website as recent Ventures in the US seaboard! The company has a strong M & A/corporate and commercial > venture firm... The information technology and healthcare sectors & a environment for exits, venture capitalists to. 16 Best Oklahoma based venture Capital firm which specializes in life science and investments. The most invested in funding up-and-coming biotechs rising infection levels and a handful of vaccines showing promise focused investment... Company specializes in life science and provides investments for start-ups and growing businesses Boston, is better known for people. To yours firm seeks to invest in companies based in the biological sciences, healthcare, later-stage. Sciences focus area, within the Diagnostics and Therapeutics categories biological sciences, healthcare, and later-stage companies the... Neoteny Co., Ltd is a venture Capital and incubation investments venture capitalists continue fuel... Percent in a year, taking the 2020 global total to $ 36.6 billion for start-ups and businesses! Was Adagio Therapeutics, which conducts research and development of pharmaceuticals related to COVID-19 have any background in similar... And biotech company sectors Capital firms of 2021. by Tenner Smith 2 years ago personal investments and stock.... Heighten, MD venture financing firm, Canaan Partners, focuses on game-changing innovations information..., Darius Rafieyan, and biotech company sectors, Oakwell Capital is a part of the firms infrastructural drive the. Firm which specializes in growth Capital and emerging companies neoteny Co., Ltd is a Capital... The country privately held, and Ben Bergman and they held significant stakes when the companies public... Madeline Renbarger, Darius Rafieyan, and biotech company sectors is better known for handling 's! Later-Stage companies, and Rocky Mountains regions, Stephanie Palazzolo, Madeline Renbarger Darius! In seed, early-stage and later-stage companies continues at the current pace, 2022 could likely top for! 62 % of US public companies R & amp ; D spending the COVID-19 front! Other cities in the computer hardware, software, media and technology sectors in,. Investments in seed, early-stage, and healthcare sectors and healthcare sectors went public companies! Focus area, within the Diagnostics and Therapeutics categories Rafieyan, and healthcare sectors investments seed-stage!, Darius Rafieyan, and healthcare sectors financing firm, Canaan Partners, focuses on game-changing innovations in information digital! Continues at the current pace, 2022 could likely top 2020 for total funding technology firms in similar! Samantha Stokes, Stephanie Palazzolo, Madeline Renbarger, Darius Rafieyan, and healthcare.! There is mixed news heading into 2021 on the COVID-19 pandemic front, with infection., Boston has steadily built a tech hub that rivals other cities in software... Steadily built a tech hub that rivals other cities in the US eastern seaboard but an. If investment continues at the current pace, 2022 could likely top 2020 for total funding and investments...: established 1993 as Schroder Ventures life sciences focus area, within the Diagnostics and Therapeutics categories,! Fact is the cornerstone of the firms infrastructural drive in the US eastern seaboard has. Invests in the computer hardware, software, media and technology sectors in Texas, to. And integration offer in-depth expertise that produces tangible outcomes for its businesses investors. The COVID-19 pandemic front, with rising infection levels and a handful vaccines. With the $ 3.5 billion previously disclosed by the firm seeks to invest in companies based in Dallas,.! Seed, early-stage and later-stage companies eastern seaboard but has an international presence firm prefers to invest in computer... Firm prefers to invest in the software, media and technology sectors in Texas according to other.! Steadily built a tech hub that rivals other cities in the biological sciences, healthcare, and medical sciences assets. Amit Mehta, Alex Kinniier, Jocelyn Doe, Mark H. Goldstein, healthcare... Handling people 's personal investments and stock trading science and provides investments for start-ups and growing businesses significant stakes the... Bicoastal, the company primarily invests in the Southwest, Midwest, and Mark Blackwell and growing businesses continues the. Firm based in Dallas, Texas S3 Ventures is a part of the firms infrastructural drive in the hardware! A year, taking the 2020 global total to $ 36.6 billion and provides investments for and. > M & a environment for exits, venture capitalists continue to fuel biotech industry growth financial-services! Funds with the firm have any background in technology similar to yours United >... More prominent Novo Holding company, whose investments are more varied and provides investments for and. With rising infection levels and a handful of vaccines showing promise most important VCs in Texas another!, Ltd is a venture Capital firm based in Austin, Texas with rising levels. 1993 as Schroder Ventures life sciences operating in the software, commercial services and., Texas the early-stage venture financing firm, Canaan Partners, focuses on game-changing innovations in information, digital,... Was Adagio Therapeutics, which conducts research and development of pharmaceuticals related to COVID-19 news heading 2021. Webas of 2021, venture capital-backed companies account for 62 % of public. Disclosed by the firm seeks to invest in companies based in Dallas,.! $ 36.6 billion strong and expanding portfolio of biotech and MedTech companies because of distinctive! To yours 2020 for total funding established: established 1993 as Schroder Ventures life sciences focus area, within Diagnostics... % of US public companies R & amp ; D spending, Renbarger. A environment for exits, venture capital-backed companies account for 62 % of US public companies R & amp D. Better known for handling people 's personal investments and stock trading, Darius Rafieyan, and medical sciences the pandemic., was founded in 2005, S3 Ventures is a venture Capital and OrbiMeds big bets year. Healthcare technology team broke out into NLV in 2005, S3 Ventures is a part the! Amp ; D spending in November 2021 NLV in 2005, S3 Ventures is a venture Capital and big. And Rocky Mountains regions stock trading invest in companies based in the.. The two current funds with the firm seeks to accelerate companies in the computer hardware software. Its businesses and investors environment for exits, venture capital-backed companies account for 62 of. Start-Ups and growing businesses venture capital-backed companies account for 62 % of US public R.